Latest News about BIIB
Recent news which mentions BIIB
3 Biotech Stocks to Watch for Potential Breakthroughs
April 11, 2023
From InvestorPlace
From Benzinga
Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
April 11, 2023
From Benzinga
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
From InvestorPlace
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
From Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Tickers
BIIB
From Benzinga
Tickers
BIIB
From MarketWatch
From InvestorPlace
Wall Street predicts approval for another ALS drug
March 21, 2023
From MarketWatch
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Tickers
BIIB
From Benzinga
From Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
From Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
From Benzinga
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
March 13, 2023
From Benzinga
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
March 09, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
